Written answers
Wednesday, 27 February 2019
Department of Health
Medicinal Products Reimbursement
Bobby Aylward (Carlow-Kilkenny, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
120. To ask the Minister for Health the reimbursement status of the drug Fasenra (benralizumab); if it has been discussed by the HSE drugs leadership group; and if he will make a statement on the matter. [9860/19]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
Bobby Aylward (Carlow-Kilkenny, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
121. To ask the Minister for Health if a decision has been made on the reimbursement of the drug Fasenra (benralizumab) by the HSE drugs leadership group; when he expects it to be made available to patients; and if he will make a statement on the matter. [9861/19]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
No comments